Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System
10:20am, Tuesday, 25'th Mar 2025
Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.
Abbott (ABT) Increases Yet Falls Behind Market: What Investors Need to Know
06:55pm, Monday, 24'th Mar 2025
Abbott (ABT) reachead $127.21 at the closing of the latest trading day, reflecting a +0.69% change compared to its last close.
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Monday, 24'th Mar 2025
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains
09:45am, Monday, 24'th Mar 2025
Five AI-powered stocks have strong revenues and earnings growth potentials for 2025. These are: MDT, LLY, BSX, NVS, ABT.
Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease
09:00am, Monday, 24'th Mar 2025
Coronary Artery Disease (CAD) is the most common heart disease and most frequent cause of death in the U.S., with over 20 million adults affected by this condition Abbott's investigational Coronary In
2025 Dividend Kings: Strong Run Continues
12:59pm, Friday, 21'st Mar 2025
The Dividend Kings are outperforming the S&P 500 in 2025 by 4.57%. Top performers include National Fuel & Gas (+30.21%), Consolidated Edison (+22.66%), and AbbVie (+20.40%). Promising Dividend Kings i
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
10:30am, Tuesday, 18'th Mar 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock?
11:16am, Monday, 17'th Mar 2025
ABT's shares rise on the back of its diversified business portfolio. However, the unfavorable macroeconomic scenario is concerning.
Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees
07:49am, Monday, 17'th Mar 2025
Abbott Laboratories is undervalued by the market, despite its strong fundamentals and strategic moves in high-growth areas like diabetes care and weight-loss treatments. The company boasts a high net
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:00am, Tuesday, 11'th Mar 2025
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
2 Dependable Dividend Stocks That Can Pay You for Life
08:15am, Friday, 07'th Mar 2025
What makes an outstanding dividend stock? High yields can seem attractive to income seekers, but unless a company has a steady, reliable business, payout cuts are a real possibility no matter how juic
Strong Earnings Lift Abbott Laboratories Shares
05:28am, Friday, 07'th Mar 2025
Health care company Abbott Laboratories (ABT) increases sales, earnings around the globe.
The Dividend Aristocrats Ranked By Quality Scores: March 2025
09:00am, Wednesday, 05'th Mar 2025
S&P Dow Jones Indices added three new members to the S&P 500 Dividend Aristocrats Index, expanding it to 69 companies. I rank Dividend Aristocrats by quality scores, presenting undervalued and overval
Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion
11:38am, Tuesday, 04'th Mar 2025
WAYNE, Penn.--(BUSINESS WIRE)-- #CLI--Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced the appointment of Paul
AHCO vs. ABT: Which Stock Is the Better Value Option?
12:46pm, Monday, 03'rd Mar 2025
Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck
